Erythropoietin for Management of Anemia Caused by Chemotherapy
A phase 2 trial of Darbepoetin alfa, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone in Diffuse large B-cell lymphoma, run by Kosin University Gospel Hospital, completed.
Overview
Erythropoietin for Management of Anemia Caused by Chemotherapy is a phase 2 interventional study registered as NCT02890602 by Kosin University Gospel Hospital, with 53 participants recorded, started 2012-09-01 and reaching its primary completion in 2017-11-28. Interventions recorded: Darbepoetin alfa, R-CHOP. Conditions recorded: Diffuse Large B-cell Lymphoma.
Linked to the drug Darbepoetin alfa because the registry names it among its interventions and Diffuse large B-cell lymphoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPrevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide and the tag pipeline.
- TrialA Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)
Shares Prednisone, Rituximab, Cyclophosphamide, Doxorubicin and the tag pipeline.
- TrialA Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide and the tag pipeline.
- TrialTucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Shares Prednisone, Vincristine, Cyclophosphamide, Doxorubicin and the tag pipeline.
- TrialA Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Shares Prednisone, Rituximab, Cyclophosphamide, Doxorubicin and the tag pipeline.
- TrialA Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
Shares Prednisone, Vincristine, Rituximab, Doxorubicin and the tag pipeline.
- TrialSafety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide and the tag pipeline.
- TrialRituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Shares Prednisone, Vincristine, Rituximab, Cyclophosphamide and the tag pipeline.